Roche Diagnostics Receives FDA Approval For Qualitative Anti-HCV Immunoassay Test On Three Analyzer …
Saturday, May 29th, 2010We recommend:
Also Included In: Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials
e-mail to a admirer pressman well-disposed purview / pen opinions
Roche Diagnostics proclaimed that the U.S. Food and Drug Administration (FDA) given Premarket Approval for its Elecsys Antibody to hepatitis C virus (anti-HCV) attempt. The Elecsys Anti-HCV check is an in-vitro symptomatic quiz for the qualitative catching of aggregate antibodies to hepatitis C virus in thrum serum or plasm.
